Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen.
Luuk J J ScheresNienke L D SelierNienke M NotaJeske J K van DiemenSuzanne C CannegieterMartin den HeijerPublished in: Journal of thrombosis and haemostasis : JTH (2021)
GAHT in transmen was not associated with apparent procoagulant changes, which provides some reassurance regarding VTE risk. In transwomen, GAHT resulted in procoagulant changes, which likely contributes to the observed increased VTE risk.